期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

丙戊酸钠对癫痫患儿体重及神经肽Y的影响

Effect of Valproic Acid Treatment on Body Weight and Neuropeptide Y in Pediatric Patients with Epilepsy
下载PDF
导出
摘要 目的:探讨丙戊酸钠(VPA)对癫痫患儿体重及神经肽Y(NPY)的影响。方法:按照纳入标准收集我院神经内科门诊2011年5月-2013年5月首次诊断癫痫后VPA单药治疗的患儿48例作为实验组,于治疗前、治疗后1、3、6个月检测患儿体质量指数(BMI)及血清NPY水平,分析两者之间的关系。另选择健康儿童24例作为对照组。结果:实验组治疗后1、3、6个月BMI及血清NPY均呈现出上升趋势,且两者在各时间点均明显高于对照组,差异具有统计学意义(P<0.05)。结论:VPA能够使癫痫患儿血清NPY水平升高,导致患儿体重增加。 Objective.To study the effect of valproic acid on body weight and serum neuropeptide Y level in pediatric patients with epilepsy. Methods：48 pediatric patients with epilepsy in experiment group who were selected according to the standard of selection during May 2011 to May 2013 were treated with VPA for 6 months. The parameters of body mass index（BMI） and serum neuropeptlde Y levels were detected before treatment and 1,3,6 months after treatment, then investigated the association between them. 24 healthy children were divided into the control group. Results.. At 1,3, 6 months after treatment in experiment group BMI and the serum neuropeptide Y both showed uptrend, which were significantly higher than those of their control group at the same time point （P〈0. 05）. Conclusion.. The serum neuropeptide Y level was increased after valproic acid treatment,which led the body weight of pediatric patients with epilepsy to increase.
作者 何晓英 付华 刘永刚 李小刚
机构地区 泸州医学院附属医院神经内科 泸州医学院附属医院乳腺外科
出处 《医学理论与实践》 2014年第3期281-282,300,共3页 The Journal of Medical Theory and Practice
关键词 丙戊酸钠 癫痫 神经肽Y Valproic Acid, Epilepsy, Neuropeptide Y
分类号 R742.1 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献11

  • 1Chang YC, Lin J J, Wang HS, et al. Intravenous valproate for seizures in 137 Taiwan Residents children-valproate naive and non-na- ive[J]. Acta Neurol Taiwan,2010,19(2) : 100-106.
  • 2Grosso S, Luisi S, Mostardini R, et al. Circulating levels of allo pregnanolone, a neuroactive steroid, and leptin during treat- ment with valproic acid in children with epilepsy[J]. Neuroen- docrinology, 2011,93(3) : 159-164.
  • 3Masuccio F, Verrotti A, Chiavaroli V, et al. Weight gain and leptin resistance in children treated with valproate: the influ- ence of time[J]. J Child Neurol, 2010,25 (8) : 941-947.
  • 4Yansu A, Serdaroglu A, Camurdan O,et al. Serum insulin, cor- :isol, leptin,neuropeptide Y, galanin and ghrelin levels in epi- eptic children receiving valproate [J]. Horm Res Paediatr, .~011,76(1):65-71.
  • 5Szekely M, Petervdri E, Pakai E, et al. Acute, subacute and chronic effects of central neuropeptide Y on energy balance in rats[J]. Neuroptides, 2005,39 (2) : 103-115.
  • 6Minor RK, Lepez M, Younts CM, et al. The arcuate nucleus and NPY contribute to the antitumorigenic effect of calorie re- striction[J]. Aging Cell, 2011,10(3) : 483-492.
  • 7Verrotti A, Manco R, Agostinelli S, et al. The metabolic syn-drome in overweight epileptic patients treated with valproic acid [J]. Epilepsia, 2010,51 (2) : 268-273.
  • 8周银娥,韩蕴丽.丙戊酸钠对癫癎患儿体质量及糖、脂代谢指标的影响[J].实用儿科临床杂志,2012,27(19):1521-1523. 被引量：4
  • 9胡春燕,李英文.神经肽Y(NPY)的生理功能研究进展[J].生物学杂志,2011,28(2):66-68. 被引量：45
  • 10Taksande BG, Kotagale NR, Nakhate KT,etal. Agmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats; involvement of neuropeptide Y[J]. Br J Pharmacol, 2011,164 (2b) ;704-718.

二级参考文献38

  • 1曲毅,魏峰涛,方宁远.NPY-Y1受体激动剂对SHR脑血管平滑肌细胞的促增殖作用[J].上海交通大学学报（医学版）,2006,26(10):1147-1149. 被引量：4
  • 2吴瑞萍,胡亚美,江载芳.诸福棠实用儿科学[M].6版.北京:人民卫生出版社,2000:2213.
  • 3Chen Z Y,Feng G G,Nishiwaki,K,et al.Possible roles of neuropeptide Y Y3-receptor subtype in rat annic endothelial cell proliferation under hypoxia,and its specific signal transduction[J].Am J Physiol Heart Circ Physiol,2007,293(2):59-67.
  • 4Wheway J,Mackay C R,Newton R A,et al.A fundamental bimodal role for neuropeptide Y1 receptor in the immune system[J].Exp Med,2005,202(11):1527-1538.
  • 5Nguyen N K,Sartorí S B,Herzng H,et al.Effect of neuropeptide Y Y2 receptor deletion on emotional stress-induced neuronal activation in mice[J].Synapse,2009,63(3):236-246.
  • 6Painsipp E,Wultsch T,Edelsbrunner M,et al.Reduced anxietylike and depression-related behavior in neuropeptide Y Y4 receptor knockout mice[J].Genes Brain Behav,2008,7(5):532-542.
  • 7Zwanziger D,Bohme I,Lindner D,et al.First selective agonist of the neuropeptide Y1-receptor with reduced size[J].Pept Sci,2009,15(12):856-866.
  • 8Walker M W,Wolinsky T D,Jubian V,et al.The novel neuropeptide Y Y5 receptor antagonist[N-[[trans4-[(4,5-dihydrobenzothiepino[5,4-d]thiazol-2-yl)amino] cycloh exyl]mthyl]methaesuf onamide]exerts anxiolytic-and antidepressant-like effects in rat models of stress sensitivity[J].Pharmacol Exp Ther,2009,328(3):900-911.
  • 9Smialowska M,Domin H,Zieba B.Neuroprotective effects of neurepeptide Y-Y2 and Y5 receptor agonists in vitro and in vivo[J].
  • 10Buckwalter J B,Hamann J J,Clifford P S.Neuropeptide Y1 receptor vasoconstriction in exercising canine skeletal muscles[J].Appl Physioi,2005,99(6):2115-2120.

共引文献47

医学理论与实践
2014年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部